Search Results - "Yildirim, Berna A."

Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients? by Yildirim, Berna A., Onal, Cem, Dolek, Yemliha

“…Purpose To compare soft-tissue cone-beam computed tomography (CBCT-P) and fiducial marker (CBCT-FM)-based image guided radiotherapy in prostate cancer…”
Get full text

Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer by Onal, Cem, Guler, Ozan C, Yildirim, Berna A

“…The aim of this work was to evaluate the prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in…”
Get more information

Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery by Onal, Cem, Efe, Esma, Guler, Ozan C, Yildirim, Berna A

“…To compare simultaneous-integrated boost (SIB) versus sequential-boost (SB) delivered in the context of whole-breast irradiation (WBI) via volumetric-modulated…”
Get full text

Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide by Topkan, Erkan, Selek, Ugur, Ozdemir, Yurday, Yildirim, Berna A., Guler, Ozan C., Ciner, Fuat, Mertsoylu, Huseyin, Tufan, Kadir

“…Introduction To evaluate the prognostic value of the Glasgow Prognostic Score (GPS), the combination of C-reactive protein (CRP) and albumin, in glioblastoma…”
Get full text

Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy by Yildirim, Berna A, Torun, Nese, Guler, Ozan C, Onal, Cem

“…PURPOSEThe aim of this study was to evaluate the prognostic importance metabolic tumor volume (MTV), total lesion glycolysis (TLG), and standardized uptake…”
Get full text

Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer by Topkan, Erkan, Selek, Ugur, Ozdemir, Yurday, Yildirim, Berna A., Guler, Ozan C., Mertsoylu, Huseyin, Hahn, Stephen M.

“…•Chemoradiotherapy is a significant source of anemia in lung cancer patients.•Low hemoglobin and resultant hypoxia induce resistance to chemoradiation…”
Get full text

The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy by Yildirim, Berna A., Guler, Ozan Cem, Kose, Fatih, Onal, Cem

“…We retrospectively analysed the prognostic significance of changes in absolute neutrophil count (ANC), absolute lymphocyte count (ALC) and…”
Get full text

Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy by Topkan, Erkan, Selek, Ugur, Ozdemir, Yurday, Yildirim, Berna A., Guler, Ozan C., Ciner, Fuat, Besen, Ali A., Findikcioglu, Alper, Ozyilkan, Ozgur

“…To investigate the incidence and influence of tumor cavitation (TC) on survival outcomes of locally advanced squamous cell lung cancer (LA-SqCLC) patients…”
Get full text

Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy by Onal, Cem, Torun, Nese, Guler, Ozan C, Yildirim, Berna A

“…BACKGROUNDThis study aimed to assess the efficacy of fluorine-18 fluorodeoxyglucose (F-FDG)-PET for predicting overall survival (OS) and disease-free survival…”
Get full text

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients by Pehlivan, Berrin, Ozyilkan, Ozgur, Mertsoylu, Huseyin, Yildirim, Berna A., Guler, Ozan C., Besen, Ali Ayberk, Ozdemir, Yurday, Selek, Ugur, Topkan, Erkan, Findikcioglu, Alper

“…We aimed to identify the fatal pulmonary hemorrhage- (FPH-) related risk factors in stage 3B/C squamous-cell lung carcinoma (SqCLC) patients treated with…”
Get full text

Lung Cancer Related Central Airway Obstruction: Who Benefits Better from Radiotherapy? by OZDEMIR, YURDAY

Get full text